Vanguard Personalized Indexing Management LLC Acquires 2,106 Shares of Tenet Healthcare Co. (NYSE:THC)

Vanguard Personalized Indexing Management LLC boosted its holdings in shares of Tenet Healthcare Co. (NYSE:THC) by 25.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,224 shares of the company’s stock after buying an additional 2,106 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Tenet Healthcare were worth $773,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its position in Tenet Healthcare by 0.6% during the third quarter. Vanguard Group Inc. now owns 10,937,483 shares of the company’s stock valued at $720,671,000 after buying an additional 63,253 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Tenet Healthcare by 16.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,516,792 shares of the company’s stock worth $114,629,000 after purchasing an additional 212,185 shares during the period. Charles Schwab Investment Management Inc. boosted its position in shares of Tenet Healthcare by 1.6% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,043,214 shares of the company’s stock worth $78,836,000 after purchasing an additional 16,490 shares during the period. Jacobs Levy Equity Management Inc. boosted its position in shares of Tenet Healthcare by 3.3% in the third quarter. Jacobs Levy Equity Management Inc. now owns 786,852 shares of the company’s stock worth $51,846,000 after purchasing an additional 25,077 shares during the period. Finally, Loomis Sayles & Co. L P boosted its position in shares of Tenet Healthcare by 5.0% in the third quarter. Loomis Sayles & Co. L P now owns 447,145 shares of the company’s stock worth $29,462,000 after purchasing an additional 21,237 shares during the period. 95.44% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. Cantor Fitzgerald reiterated an “overweight” rating and issued a $104.00 price target on shares of Tenet Healthcare in a research report on Wednesday, April 10th. UBS Group boosted their target price on shares of Tenet Healthcare from $137.00 to $150.00 and gave the stock a “buy” rating in a report on Wednesday, May 1st. Royal Bank of Canada boosted their target price on shares of Tenet Healthcare from $109.00 to $136.00 and gave the stock an “outperform” rating in a report on Wednesday, May 1st. Mizuho reissued a “buy” rating and issued a $130.00 target price (up previously from $118.00) on shares of Tenet Healthcare in a report on Wednesday, May 1st. Finally, Barclays upped their price target on shares of Tenet Healthcare from $113.00 to $147.00 and gave the company an “overweight” rating in a research note on Thursday, May 2nd. One equities research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $113.19.

Insider Transactions at Tenet Healthcare

In other Tenet Healthcare news, Director Nadja West sold 1,782 shares of the stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $126.41, for a total transaction of $225,262.62. Following the transaction, the director now directly owns 29,680 shares in the company, valued at approximately $3,751,848.80. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Tenet Healthcare news, Director Nadja West sold 1,782 shares of the stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $126.41, for a total transaction of $225,262.62. Following the transaction, the director now directly owns 29,680 shares in the company, valued at approximately $3,751,848.80. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Richard W. Fisher sold 2,500 shares of the stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $123.20, for a total transaction of $308,000.00. Following the transaction, the director now owns 17,627 shares in the company, valued at $2,171,646.40. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 61,598 shares of company stock worth $6,238,815. Insiders own 0.93% of the company’s stock.

Tenet Healthcare Trading Down 0.5 %

NYSE THC opened at $130.32 on Wednesday. The company’s 50-day moving average price is $108.18 and its 200-day moving average price is $88.96. The company has a current ratio of 1.44, a quick ratio of 1.37 and a debt-to-equity ratio of 2.58. The stock has a market cap of $12.73 billion, a PE ratio of 5.06, a PEG ratio of 1.33 and a beta of 2.09. Tenet Healthcare Co. has a 12 month low of $51.04 and a 12 month high of $133.17.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $3.22 EPS for the quarter, topping analysts’ consensus estimates of $1.45 by $1.77. The firm had revenue of $5.37 billion for the quarter, compared to analysts’ expectations of $5.15 billion. Tenet Healthcare had a net margin of 12.53% and a return on equity of 26.76%. The business’s revenue for the quarter was up 6.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.42 earnings per share. Equities research analysts forecast that Tenet Healthcare Co. will post 8.72 earnings per share for the current year.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.